Patterns of failure and toxicity profile following proton beam therapy for pediatric bladder and prostate rhabdomyosarcoma (B/P-RMS).
07/08/2019
/
Publications
/
Toxicity
This study reported outcomes of 19 patients of B/P-RMS treated with PBT. With a median follow-up of 66.2 months, 5-year overall survival (OS) and progression...
Outcome and patterns of relapse in childhood parameningeal rhabdomyosarcoma treated with PBT.
07/08/2019
/
Publications
Published in the Red Journal, the study by WPE reported outcomes of PBT for 46 pediatric patients with parameningeal rhabdomyosarcoma (pRMS). Wit a median...
Practice patterns among radiation oncologists treating pediatric patients with proton craniospinal irradiation.
07/07/2019
/
Publications
This survey study aimed to assess current practice patterns regarding the vertebral bodies (VB) coverage for pediatric patients undergoing CSI. With the 28...
Proton Beam Therapy for Histologically or Clinically Diagnosed Stage I Non-small Cell Lung Cancer (NSCLC): The First Nationwide Retrospective Study in Japan.
07/10/2019
/
Publications
Six hundred sixty-nine patients with 682 tumors with histologically or clinically diagnosed Stage I NSCLC who received passive-scattering PBT in Japan were...
Proton therapy for locally advanced NSCLC
10/10/2019
/
Publications
A review article by MD Anderson group. Using particle-beam therapy rather than photons offers the potential for further advantages because of the unique depth...
TORPEdO - Phase III Trial of IMPT Vs IMRT for Multi-toxicity Reduction in Oropharyngeal Cancer.
07/10/2019
/
Publications
/
IMPT
Chemotherapy
IMRT
This is the UK's first proton clinical trial. Published in the Clinical Oncology, this editorial provided the rational and the plan of the trial. It is a...
Early clinical outcomes of helical tomotherapy/IMPT combination in nasopharynx cancer.
07/07/2019
/
Publications
/
IMPT
Chemotherapy
A study from Korea evaluated the feasibility of combining helical Tomotherapy (HT) and intensity-modulated proton therapy (IMPT) in treating patients with...
Show & Tell #4: Gastrointestinal Cancers
02/10/2021
/
Event
/
Watch this Show and Tell on Gastrointestinal cancers.
Dr Andrew J. Wroe, Director of Proton Physics, and Dr Adeel Kaiser, Radiation Oncologist, will share...
Phase II Study of PBRT for Patients With Breast Cancer Requiring Regional Nodal Irradiation.
07/08/2019
/
Publications
/
Chemotherapy
Survival
This study evaluated 70 patients among who 63 patients (91%) had left-sided breast cancer, two had bilateral breast cancer, and five had right-sided breast...
Pragmatic randomised clinical trial of PT vs photon therapy for patients with non-metastatic breast cancer
07/10/2019
/
Publications
This is the trial protocol of RadComp. This multi-center trial sets the objective to evaluate whether the differences between proton and photon therapy cardiac...
Video Player is loading.
Current Time 0:00
/
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time -0:00
1x
Chapters
descriptions off, selected
captions settings, opens captions settings dialog
captions off, selected
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
Cookies policy
If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.
Manage your cookie preferences
Respect for your privacy is still a priority for us at IBA.
Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.
iba-campus- cookies-consent
Used for cookie consent to comply with GDPR.
SESS(followed by a long string of characters)
Drupal user session cookie
VISITOR_INFO1_LIVE
This cookie is set by Youtube to keep track of user preferences for Youtube videos embedded in sites; it can also determine whether the website visitor is using the new or old version of the Youtube interface.
_ga
This cookie name is associated with Google Universal Analytics - which is a significant update to Google's more commonly used analytics service. This cookie is used to distinguish unique users by assigning a randomly generated number as a client identifier. It is included in each page request in a site and used to calculate visitor, session and campaign data for the sites analytics reports. By default it is set to expire after 2 years, although this is customisable by website owners.
_ga_Q8N0175HHW
set by Google Analytics
_hjAbsolute SessionInProgress
The cookie is set so Hotjar can track the beginning of the user's journey for a total session count. It does not contain any identifiable information.
_hjIncludedInPageviewSample
This cookie is set to let Hotjar know whether that visitor is included in the data sampling defined by your site's pageview limit.
_hjIncludedInSessionSample
This cookie is set to let Hotjar know whether that visitor is included in the data sampling defined by your site's pageview limit.
_hjSessionUser_xxxxxx
Hotjar cookie that is set when a user first lands on a page with the Hotjar script. It is used to persist the Hotjar User ID, unique to that site on the browser. This ensures that behavior in subsequent visits to the same site will be attributed to the same user ID.
visitor_id#####
This is a cookie pattern that appends a unique identifier for a website visitor, used for tracking purposes. The cookies is set by pardot.com and have a lifespan of 10 years.
lpv928513
Cookie set by pi.pardot.com
YSC
This cookie is set by YouTube to track views of embedded videos. The main purpose of this cookie is: Performance